Biorez
-
Biologics
Biorez Announces FDA 510(k) Clearance of Its Proprietary BioBrace™ Implant Technology
The BioBrace implant represents the first biocomposite soft tissue scaffold designed to reinforce tendon and ligament repairs, promote healing, and…
Read More » -
Biologics
Biorez Preclinical Results to be Presented at the ORS 2021 Annual Meeting
Multiple studies demonstrate the company’s BioBrace™ scaffold is a novel implant technology to reinforce surgical repairs and augment soft tissue…
Read More » -
Financial
Biorez Raises $3.5 Million to Advance Tendon and Ligament Repair
NEW HAVEN, CONN. (PRWEB) SEPTEMBER 09, 2020 Biorez, Inc., a medical device company advancing tendon and ligament repair, announced today that…
Read More » -
Biologics
Soft Tissue Regeneration Raises Series C Financing and Rebrands to Biorez
NEW HAVEN, CONN. (PRWEB) MARCH 14, 2017 Biorez, Inc., formerly known as Soft Tissue Regeneration, Inc., today announced the close…
Read More »